EVALUATION OF SILYL-BLOCKED P-NITROPHENYLMALTOHEPTAOSIDE AS A SUBSTRATE FOR ALPHA-AMYLASE REAGENTS

被引:0
作者
ELBIN, CS
BECKS, S
LEPP, CA
机构
[1] CIBA CORNING DIAGNOST CORP,DEPT SYST ENGN,OBERLIN,OH 44074
[2] OLYMPUS CORP,DIV CLIN INSTRUMENTS,LAKE SUCCESS,NY 11042
关键词
ENZYME ACTIVITY; SYNTHETIC SUBSTRATES; BICHROMATIC ANALYSIS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We describe a reagent for measuring alpha-amylase (EC 3.2.1.1) activity in serum with use of a thexyldimethylsilyl ether of p-nitrophenyl-alpha-D-maltoheptaoside (SB7) as substrate. This substrate differs from Genzyme's benzylidene-blocked p-nitrophenylmaltoheptaoside substrate (B-PNPG7). The reagent, optimized for the characteristics of the silyl-blocked substrate, contains 4-(2-hydroxyethyl)-1-piperazineethane sulfonate buffer at pH 7.3, alpha-glucosidase (maltase; EC 3.2.1.20), and glucoamylase (EC 3.2.1.3). Comparison with Ciba Corning Diagnostics Corp.'s, amylase reagent with B-PNPG7 as substrate (x) yielded a regression equation of y = 1.20x - 2.7 (r = 0.9997). The linear range exceeded amylase concentrations >2500 U/L and total precision (CV) was 2.3% at an amylase concentration of 112 U/L with the Ciba Coming 550 Express(R) analyzer. Reconstituted reagent is stable for 30 days at 5-degrees-C and 7 days at ambient (18-25-degrees-C) temperatures.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 9 条
  • [1] ANDERSON G, 1991, CLIN CHEM, V37, P398
  • [2] Blair HE, 1987, US Patent, Patent No. [US4649108A, 4649108]
  • [3] Porterfield R.I., 1984, MED DEVICE DIAGN IND, V6, P45
  • [4] RAUSCHER E, 1985, CLIN CHEM, V31, P14
  • [5] RAUSCHER E, 1987, Patent No. 4709020
  • [6] 1986, NCCLS EP9P PUBL
  • [7] 1986, ANN BIOL CLIN, V44, P686
  • [8] 1986, NCCLS EP10P PUBL
  • [9] 1986, NCCLS EP6P PUBL